Palantir Technologies Secures Multi-Year Agreement with OneMedNet to Enhance Healthcare AI and Data Analytics
Reuters
Yesterday
Palantir Technologies Secures Multi-Year Agreement with OneMedNet to Enhance Healthcare AI and Data Analytics
Palantir Technologies Inc. has announced that OneMedNet Corporation has selected its Artificial Intelligence Platform to enhance healthcare AI and real-world data analytics. Under the multi-year agreement, Palantir's platform will provide the infrastructure for OneMedNet's provider network, enabling near real-time access to anonymized, regulatory-grade clinical data and advanced analytics. The collaboration aims to accelerate the development of medical solutions for life sciences, medical device, and research organizations. The integration will allow customers to fulfill data inquiries more quickly, create custom data cohorts, and utilize an AI-powered conversational search interface. Palantir's technology will also support automation and healthcare standards integration to improve OneMedNet's operational efficiency and scalability.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palantir Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251006304673) on October 06, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.